within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02A_CorticosteroidsForSystemicUsePlain.H02AB07_Prednisone;

model Prednisone
  extends Pharmacolibrary.Drugs.ATC.H.H02AB07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H02AB07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Prednisone is a synthetic glucocorticoid corticosteroid drug used primarily to suppress the immune system and reduce inflammation in conditions such as asthma, rheumatoid arthritis, allergic disorders, and autoimmune diseases. It is also sometimes used in certain cancers as part of the treatment. Prednisone is an approved and widely used medication in current medical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>de Truchis, C, et al., &amp; Boyer, O (2023). Prednisolone pharmacokinetics after oral prednisone administration in paediatric patients with kidney transplant. <i>British journal of clinical pharmacology</i> 89(5) 1532–1540. DOI:<a href=&quot;https://doi.org/10.1111/bcp.15610&quot;>10.1111/bcp.15610</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36510685/&quot;>https://pubmed.ncbi.nlm.nih.gov/36510685</a></p></li><li><p>Sebbag, L, &amp; Mochel, JP (2020). Pharmacokinetics of Oral Prednisone at Various Doses in Dogs: Preliminary Findings Using a Naïve Pooled-Data Approach. <i>Frontiers in veterinary science</i> 7 571457–None. DOI:<a href=&quot;https://doi.org/10.3389/fvets.2020.571457&quot;>10.3389/fvets.2020.571457</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33195563/&quot;>https://pubmed.ncbi.nlm.nih.gov/33195563</a></p></li><li><p>Sebbag, L, et al., &amp; Mochel, JP (2019). Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 35(6) 341–349. DOI:<a href=&quot;https://doi.org/10.1089/jop.2019.0020&quot;>10.1089/jop.2019.0020</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31070497/&quot;>https://pubmed.ncbi.nlm.nih.gov/31070497</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Prednisone;
